Published in J Alzheimers Dis on January 01, 2012
Induced pluripotent stem cells to model and treat neurogenetic disorders. Neural Plast (2012) 0.88
Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study. BMJ Open (2013) 0.78
A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy. Int J Mol Sci (2015) 0.78
Pathophysiological implications of neurovascular P450 in brain disorders. Drug Discov Today (2016) 0.76
A Review of Biomarkers for Alzheimer's Disease in Down Syndrome. Neurol Ther (2017) 0.76
Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement (2015) 0.75
Genotypic and allelic variability in CYP19A1 among populations of African and European ancestry. PLoS One (2015) 0.75
Pharmacotherapeutic Considerations for Individuals with Down Syndrome. Pharmacotherapy (2016) 0.75
Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors. Front Neuroendocrinol (2016) 0.75
The CYP19A1 rs3751592 variant confers susceptibility to Alzheimer disease in the Chinese Han population. Medicine (Baltimore) (2016) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res (1990) 14.82
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron (2007) 6.88
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med (1989) 3.24
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet (2000) 2.82
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med (1998) 2.20
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem (1996) 2.06
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet (2003) 1.88
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82
17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun (1995) 1.80
Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A (2005) 1.67
Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab (1999) 1.67
Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc (1998) 1.66
Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol (2003) 1.66
The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev (1988) 1.56
Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging (2006) 1.38
Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res (1998) 1.38
Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology (2004) 1.34
Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol (1985) 1.34
Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol (2008) 1.32
Diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res (1997) 1.26
A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer (2000) 1.26
Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem (1994) 1.25
Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A (1992) 1.23
Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol (2004) 1.19
Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology (2000) 1.18
Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology (2004) 1.15
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab (2001) 1.13
Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology (2000) 1.05
Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res (2001) 1.05
HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. Int J Cancer (2003) 1.02
Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiracial/multiethnic, multisite study of women at midlife. Am J Med (2006) 1.01
Onset of dementia is associated with age at menopause in women with Down's syndrome. Ann Neurol (2003) 1.00
Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging (2006) 1.00
Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav (2002) 0.98
Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology (2000) 0.93
CYP19 haplotypes increase risk for Alzheimer's disease. J Med Genet (2006) 0.91
Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome. Neurosci Lett (2006) 0.91
Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study. Breast Cancer Res (2004) 0.90
Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer (1999) 0.90
Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement Geriatr Cogn Disord (2005) 0.89
Obesity enhances verbal memory in postmenopausal women with Down syndrome. Neurobiol Aging (2004) 0.89
Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause (2008) 0.89
Association of the aromatase gene with Alzheimer's disease in women. Neurosci Lett (2009) 0.88
Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiol Aging (2008) 0.87
Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol (2003) 0.86
Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease. Neurobiol Aging (2004) 0.86
Sex hormone binding globulin and aging. Horm Metab Res (2008) 0.85
Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women. Dement Geriatr Cogn Disord (2009) 0.84
Expression of CYP19 (aromatase) mRNA in the human temporal lobe. Biochem Biophys Res Commun (1998) 0.84
A model for predicting age at menopause in white women. Fertil Steril (2006) 0.83
Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease. Dement Geriatr Cogn Disord (2004) 0.83
A common polymorphism in the 5'-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol (2004) 0.83
Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk. J Neural Transm (Vienna) (2008) 0.83
Serum levels of sex hormone-binding globulin (SHBG) are not associated with lower levels of non-SHBG-bound testosterone in male newborns and healthy adult men. Clin Endocrinol (Oxf) (2005) 0.80
Body weight, estrogen and cognitive functioning in Alzheimer's disease: an analysis of the Tacrine Study Group data. Arch Gerontol Geriatr (2004) 0.78
Effect of menopause on cognitive performance in women with Down syndrome. Neuroreport (2001) 0.78
The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuro Endocrinol Lett (2002) 0.77
The history of cancer epigenetics. Nat Rev Cancer (2004) 14.38
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Mol Cancer Ther (2007) 7.08
Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet (2008) 5.66
An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res (2007) 5.63
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell (2011) 3.83
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Retracted Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature (2013) 3.35
Activation of p53 by MEG3 non-coding RNA. J Biol Chem (2007) 3.07
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol (2005) 2.33
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol (2006) 2.21
Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol (2002) 2.17
HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res (2010) 2.11
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol (2011) 2.01
Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol (2003) 2.01
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88
Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell (2006) 1.81
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80
Predictors of ovulatory failure in women with epilepsy. Ann Neurol (2002) 1.75
Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) (2011) 1.74
CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. Am J Pathol (2004) 1.72
Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res (2008) 1.70
Placental overgrowth in mice lacking the imprinted gene Ipl. Proc Natl Acad Sci U S A (2002) 1.67
Astressin B, a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey. Endocrinology (2007) 1.59
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59
Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport (2007) 1.57
Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol (2012) 1.55
Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology (2012) 1.54
Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52
Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol (2005) 1.48
Essential tremor is associated with dementia: prospective population-based study in New York. Neurology (2009) 1.45
Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet (2010) 1.44
Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc (2005) 1.44
Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology (2010) 1.37
Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet (2011) 1.36
Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet (2010) 1.32
Placental growth retardation due to loss of imprinting of Phlda2. Mech Dev (2004) 1.32
Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch Neurol (2002) 1.28
Methods in DNA methylation profiling. Epigenomics (2009) 1.25
Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy? Semin Cell Dev Biol (2009) 1.23
Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab (2003) 1.23
Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease. Neurogenetics (2007) 1.22
Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci (2010) 1.22
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL. Blood (2011) 1.22
Four new families with autosomal dominant partial epilepsy with auditory features: clinical description and linkage to chromosome 10q24. Epilepsia (2002) 1.21
Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet (2006) 1.19
Association of C-reactive protein with cognitive impairment. Arch Neurol (2010) 1.19
Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome. Arch Neurol (2007) 1.19
Down's syndrome and Alzheimer's disease: towards secondary prevention. Nat Rev Drug Discov (2012) 1.18
A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons. Cancer Res (2006) 1.17
Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol (2002) 1.17
Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord (2007) 1.16
Telephone-based identification of mild cognitive impairment and dementia in a multicultural cohort. Arch Neurol (2011) 1.15
Plasma ß-amyloid and cognitive decline. Arch Neurol (2010) 1.13
Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available cMet kinase inhibitor in human tumor xenograft mouse models. Drug Metab Dispos (2008) 1.12
Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging (2008) 1.10
Coding mutations in SORL1 and Alzheimer disease. Ann Neurol (2015) 1.09
Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders. Mov Disord (2010) 1.09
The caBIG® Life Science Business Architecture Model. Bioinformatics (2011) 1.07
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing (2008) 1.07
Incidence and prevalence of dementia in elderly adults with mental retardation without down syndrome. Am J Ment Retard (2004) 1.07
Phosphoinositide binding by the pleckstrin homology domains of Ipl and Tih1. J Biol Chem (2002) 1.05
Dementia in adults with mental retardation: assessment at a single point in time. Am J Ment Retard (2004) 1.05
Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab (2004) 1.05
Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome. Neurosci Lett (2007) 1.04
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. J Am Soc Nephrol (2009) 1.04
Biallelic expression of HRAS and MUCDHL in human and mouse. Hum Genet (2003) 1.04
Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dement Geriatr Cogn Disord (2008) 1.03
Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril (2008) 1.03
Functional correlates of mild parkinsonian signs in the community-dwelling elderly: poor balance and inability to ambulate independently. Mov Disord (2006) 1.03
Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS One (2010) 1.03
APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals. Arch Neurol (2004) 1.02
Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor. Mol Cancer Ther (2012) 1.02
Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol Aging (2005) 1.01
Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis (2011) 1.01